PM Images Written by Nick Ackerman. Any investor can be a dividend investor, whether for those who are already in retirement or those looking to grow their portfolio over time. Monthly dividends can be great for investors who are retired, as that can help match up with recurring monthly expenses. For those just focusing on building up an income portfolio, the more frequent payments can also keep one more disciplined to stick with their investment approach. Today, I wanted to highlight 2 choices that have be ...

LAUSANNE, Switzerland, May 30, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will present a company overview at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 11:30 a.m. ET. A live webcast of the presentation will be available via the Events & Presentations page in the Investors section of ADC Therapeutics’ website at ir.adctherapeutics.com. A replay of the webcast will be available for approximately 30 days. Ab ...

Agree Realty is a large net-lease REIT, with an attractive yield and plenty of opportunity for growth ahead of it.Agree Realty (ADC -0.62%) has a lofty dividend yield of 5%, which is drastically higher than the 1.3% on offer from the S&P 500 and notably above the 4.3% from the average real estate investment trust (REIT), using Vanguard Real Estate Index ETF (VNQ -0.97%) as a proxy.But is this high-yield REIT the right dividend stock for you? Here's what you need to know.Agree Realty had a tough year in 2011 ...

-BHV-1510 is a novel trophoblast cell surface antigen-2 (Trop-2) directed antibody drug conjugate (ADC) that has demonstrated a highly differentiated preclinical monotherapy efficacy profile, the potential for broader therapeutic margin than other Trop-2 ADCs currently in development, and synergistic affects when combined with anti-PD1 therapy-Biohaven also entered into a clinical supply agreement with Regeneron to study the combination of BHV-1510 with Regeneron's anti-PD-1 Libtayo® (cemiplimab-rwlc) in th ...

Image Source This article was co-produced with Wolf Report. It all comes down to what you want from your investments. Some of you want 300-500% RoR from an investment in a short time. If that's what you want here, I suggest that you stop reading. Today I'm sticking with safe stocks. The generation of safe, reliable, continuous income above the market level, while protecting my capital and my downside. We're looking for no less than 4-5% yield on average, with a 10-13% capital appreciation potential or there ...

- New Positive Phase 2 Results in Metastatic Triple Negative Breast Cancer (mTNBC) Indicate That Use of Trilaciclib in Combination with a TROP2 ADC May Be Associated with Improved Median OS Compared to Historical Data for the ADC Alone - - Exploratory Analysis of a More Comparable Patient Population Showed an Approximately Six-Month Improvement in Median OS Among Patients Receiving Trilaciclib in Combination with the ADC Compared to Historical ADC Data - - Prolonged OS Observed in Patients Receiving Trilaci ...

YvanDube On our previous coverage of Agree Realty Corporation (NYSE:ADC) we compared it to WP Carey (WPC). WPC was the one that ultimately made it higher on our priority list. Those income investors are going to come back to this, probably in the early 2030s. WPC is likely to be in the penalty box, and valuation expansion won't be happening anytime soon. That said, objectively, if we can get past the misstep, WPC does have a splendid portfolio and one that could really do well if we enter a secular inf ...

porcorex It certainly doesn't hurt to own high-flying stocks like Dell Technologies Inc. (DELL) and NVIDIA Corporation (NVDA) these days, as the capital appreciation on these stocks over the past year has been equivalent to multiple years of market-level performance. Holding those stocks, however, can represent a dilemma for some investors, as it'd be unrealistic for any stock, no matter how great the business, to sustain the types of rallies they've recently had over the long run. This means that investors ...

SUZHOU, China, May 26, 2024 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE (Nasdaq: BNTX, "BioNTech"), a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases, under which BioNTech will receive an exclusive option to an exclusive global license to apply MediLink's TMALIN® antibody-drug conjugate (ADC) platform, for several novel targets cho ...

J. Michael Jones/iStock Editorial via Getty Images I've been buying more of Agree Realty's (NYSE:ADC) common and preferred shares since the start of the year in response to the continued weakness of these securities. The commons are down 9% over the last 1 year with the 4.25% Series A preferreds (NYSE:ADC.PR.A) trading at a material 32% discount to their $25 per share liquidation value. The commons last declared a monthly cash dividend of $0.250 per share, kept unchanged from the prior month and $3 per ...